It is therefore relevant to explore how treatment with insulin and insulin analogs influence the behaviour of existing cancers, and to do this in animal models of diabetes or obesity combined with insulin resistance, since these factors are known risk factors for cancer development. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.